PPAR??激动剂罗格列酮对人乳腺癌细胞生长 抑制及诱导凋亡作用研究

目的:观察氧化酶体激活物增殖受体(PPARγ)激动剂罗格列酮(ROZ)在体外激活PPARγ后对MCF-7细胞的生长抑制及诱导凋亡作用。方法:MTT法检测ROZ对MCF-7细胞的生长抑制作用;集落形成实验观察ROZ对MCF-7细胞集落形成的影响;不同浓度ROZ作用72h,Hoechst33342染色观察MCF-7细胞的形态变化,流式细胞光度分析术(FCM)检测凋亡细胞百分率以及ROZ对细胞周期的影响;Western blot方法检测ROZ对MCF-7细胞Bcl-2、Caspase-3表达的影响。结果:ROZ可呈剂量依赖性抑制MCF-7细胞的生长及集落形成。ROZ浓度为6×10-5M和3×10-4M时则G1期细胞数明显增加,S期相应减少。Hoechst33342染色经ROZ处理的肿瘤细胞染色质呈颗粒状,且有凋亡小体出现。FCM检测结果显示,ROZ作用72h凋亡细胞数达22.05%。Western blot提示ROZ可抑制Bcl-2表达,促进Caspase3表达。结论:ROZ在体外可抑制MCF-7细胞的增殖并诱导其凋亡,这可能与其抑制Bcl-2表达、促进caspase3表达有关。提示ROZ有望成为乳腺癌治疗药或肿瘤治疗的辅助用药,PPARγ有潜力成为肿瘤治疗的新靶点。     

小??和凤头??越冬潜水行为及差异

2013年10月—2014年3月,采用焦点动物法观察了小??Tachybaptus ruficollis和凤头??Podiceps cristatus的越冬潜水行为。小??的平均潜水持续时间和暂停持续时间分别为(13.84 s±5.66 s)(n=1593)和(12.24 s±9.71 s)(n=1504),凤头??为(21.72 s±9.65 s)(n=793)和(17.88 s±11.68 s)(n=728),均在越冬不同时期和昼间不同时段有所差异。小??(1.13)和凤头??(1.21)的潜水效率均较低,小??的潜水效率更为稳定。2个物种中,仅小??的暂停持续时间与前一次和后一次的潜水有极显著相关性。2种??在潜水持续时间长及潜水效率高的时段均相似,但也产生了"错峰"等分化现象。本文还验证了潜水持续时间随体型增大而增长,温度下降会导致潜水效率下降等规律。     

娇俏的小??

正说起城市里的鸟类,在许多城市水体中,我们都会看到一种喜爱在水中时而游弋、时而潜水的小鸭子般的小鸟,其实它们可不是鸭子,它们的真名叫做小??。相信很多朋友依旧对这两个汉字犯晕,这次再强调一下,读音是?(pì)?(tī)。这两个字可不是现代鸟类学家生造出来的,而是古汉字里就有的,有时候也会被写作"鷿?"。而今天,     

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors

As important members of nuclear receptor superfamily, Peroxisome proliferator-activated receptors (PPAR) play essential roles in regulating cellular differentiation, development, metabolism, and tumorigenesis of higher organisms. The PPAR receptors have 3 identified subtypes: PPARα, PPARβ and PPARγ, all of which have been treated as attractive targets for developing drugs to treat type 2 diabetes. Due to the undesirable side-effects, many PPAR agonists including PPARα/γ and PPARβ/γ dual agonists are stopped by US FDA in the clinical trials. An alternative strategy is to design novel pan-agonist that can simultaneously activate PPARα, PPARβ and PPARγ. Under such an idea, in the current study we adopted the core hopping algorithm and glide docking procedure to generate 7 novel compounds based on a typical PPAR pan-agonist {"type":"entrez-nucleotide","attrs":{"text":"LY465608","term_id":"1257853743","term_text":"LY465608"}}LY465608. It was observed by the docking procedures and molecular dynamics simulations that the compounds generated by the core hopping and glide docking not only possessed the similar functions as the original {"type":"entrez-nucleotide","attrs":{"text":"LY465608","term_id":"1257853743","term_text":"LY465608"}}LY465608 compound to activate PPARα, PPARβ and PPARγ receptors, but also had more favorable conformation for binding to the PPAR receptors. The additional absorption, distribution, metabolism and excretion (ADME) predictions showed that the 7 compounds (especially Cpd#1) hold high potential to be novel lead compounds for the PPAR pan-agonist. Our findings can provide a new strategy or useful insights for designing the effective pan-agonists against the type 2 diabetes.     

甘肃省鸟类新记录——角??

正2020年1月5日11∶30,在甘肃省张掖市张掖国家湿地公园(100°26'16″E,38°58'18″N,海拔1 462 m)进行鸟类调查时,发现3只角??Podiceps auritus,并拍摄到其在水中觅食、追逐和嬉戏的清晰照片(图1)。经查阅《中国鸟类野外手册》(约翰·马敬能等,2000)、《中国鸟类分类与分布名录(第三版)》(郑光美,2017)等相关文献资料,确认该鸟为甘肃省分布新记录,该发现为了解其地理分布提供了基础资料。     

PPARα、PPARγ及其双激动剂与动脉粥样硬化

过氧化物酶体增殖物激活受体（peroxisome proliferator-activated receptors,PPARs）是核受体超家族中的一类配体依赖的核转录因子,其中两种重要的亚型PPARα和PPARγ在脂肪细胞分化、能量代谢和炎症过程中都发挥重要作用。研究显示,PPARα和PPARγ的配体激动剂不仅可以改善包括糖尿病、高血压和肥胖等在内的胰岛素抵抗综合征,而且还可以通过作用于血管壁从而减缓动脉粥样硬化的进程。本文将就PPARα和PPARγ及其双激动剂与动脉粥样硬化发病机制和治疗的相关研究进展进行概括介绍。     

激活PPARα缓解PPARγ诱导的小鼠脂肪肝

目的研究PPARα激活后对PPARγ诱导小鼠脂肪肝的影响。方法以4~5周龄C57BL/6J小鼠为模型,实验分为4组:正常饮食组;0.125%Wy-14,643处理组;PPARγ腺病毒(Ad/PPARγ)注射组;先给予0.125%Wy-14,643饮食再注射Ad/PPARγ组。实验结束时,收集肝脏组织称重、照相,HE、油红O染色观察PPARα激活后对PPARγ诱导肝脏脂肪变性的影响。结果野生型小鼠给予PPARα激动剂Wy-14,643处理8 d,与对照组相比,处理组小鼠肝脏明显增大,呈现过氧化物酶体增殖反应;野生型小鼠给予Ad/PPARγ5 d,小鼠肝脏显著增大,出现脂肪肝;给予PPARα激动剂Wy-14,643 3 d,再给予Ad/PPARγ5 d,小鼠肝脏增大更加显著,HE染色、油红O染色结果显示小鼠肝脏脂肪变性明显减轻。结论激活PPARα能够缓解PPARγ诱导的小鼠肝脏脂肪变,为脂肪肝的预防和治疗提供了新的研究思路和靶点。     

PPARα and PPARγ regulate the nucleoside transporter hENT1

Human equilibrative nucleoside transporter 1 (hENT1) is an important determinant for nucleoside analog based chemotherapy success. Preliminary data suggest hENT1 regulation by PPARs. Using A2780 cells, we investigated the role of PPARs on hENT1 expression and activity. PPARα and PPARγ agonists, Wy14,643 and RGZ, increased hENT1 expression, but only PPARα activation or overexpression resulted in higher hENT1 transport activity. On the other hand, promoter analysis showed two putative PPRE in hENT1 promoter and luciferase-coupled promoter constructs were generated and analyzed. Our results suggest that PPARα-but not PPARγ-mediated expression regulation of hENT1 is PPRE-dependent. In conclusion, PPARα and PPARγ activation modulate hENT1 expression.     

Formation of Non-Native ??-Lactoglobulin during Heat-Induced Denaturation

A mechanism describing the denaturation and aggregation behavior during heat-treatment of pure β-lactoglobulin and β-lactoglobulin in whey protein isolate (WPI) under selected conditions (20 to 90 gL⁻¹ in water at pH 7.0, 78 °C) is presented. A combination of reversed-phase and gel permeation chromatography was used to study the disappearance of native β-lactoglobulin and the formation of non-native intermediates in the aggregation process. The mean reaction order for pure β-lactoglobulin and β-lactoglobulin in WPI were the same, 1.4. While the rate of β-lactoglobulin denaturation was greater in WPI there was less aggregation compared to that of pure β-lactoglobulin. More of the β-lactoglobulin in WPI remained in a non-native monomer intermediate state after 30 min of heating. After an initial lag period, during which non-native monomers appeared, aggregates formed and rapidly reached a plateau in terms of their size. These aggregates were visualized using atomic force microscopy. There was no significant effect of protein concentration on either aggregate size or the number of exposed sulfhydryls in the heated solutions.     

畜禽PPARα基因研究进展

过氧化物酶体增殖物激活受体(Peroxisome proliferator-activated receptors,PPARs)是核激素受体家族中的配体激活受体,控制许多细胞内的代谢过程,PPARα作为过氧化物酶体增殖物激活受体家族重要成员之一,是调控机体脂质代谢的重要枢纽,在调控畜禽机体肝脏脂质代谢方面有重要作用。PPARα基因由四个结构域组成,多在机体肝脏和脂肪组织中表达,可作为细胞核受体被外源和内源的特异性配体结合并激活,进而结合靶基因发挥对肝脏脂质代谢的调控作用。就PPARα基因的结构特点及表达模式、PPARα基因对肝脏脂代谢的调控机制,以及现阶段PPARα在畜禽方面的研究进展进行阐述,旨在引起人们对PPARα基因调控脂质代谢的关注,并为畜禽肝脏脂质代谢过程的机理研究和相关疾病的治疗提供一些理论支持。     

PPAR基因与脂肪代谢调控

过氧化物酶体增值剂激活受体(PPARs)基因属于类固醇/甲状腺/维甲酸受体超家族,有3个亚型,即：PPAR-α、PPAR-β和PPAR-γ。PPARs具有多种生物学功能,如增强机体对胰岛素敏感性,调节体内糖平衡等,尤其在脂肪分化、生成等多方面起到重要作用,是目前的研究热点,文章从PPARs基因的结构,表达及功能等方面讨论了其与脂肪代谢调控的关系。     

PPARγ与代谢性疾病

过氧化物酶体增殖物激活受体γ(PPARγ)是一种可由多种脂肪酸及其衍生物激活的核转录因子,在机体糖脂代谢中起重要调节作用,一些可作为其配体的合成化合物现已应用于Ⅱ型糖尿病的临床治疗。该简单介绍PPARγ作用的分子机制以及PPARγ与一些代谢性疾病的关系。     

Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators

We describe the synthesis of 26 compounds, small polycerasoidol analogs, that are Lipinski’s rule-of-five compliant. In order to confirm key structural features to activate PPARα and/or PPARγ, we have adopted structural modifications in the following parts: (i) the benzopyran core (hydrophobic nucleus) by benzopyran-4-one, dihydrobenzopyran or benzopyran-4-ol; (ii) the side chain at 2-position by shortening to C3, C4 and C5-carbons versus C-9-carbons of polycerasoidol; (iii) the carboxylic group (polar head) by oxygenated groups (hydroxyl, acetoxy, epoxide, ester, aldehyde) or non-oxygenated motifs (allyl and alkyl). Benzopyran-4-ones 6, 12, 13 and 17 as well as dihydrobenzopyrans 22, 24 and 25 were able to activate hPPARα, whereas benzopyran-4-one (7) with C5-carbons in the side chain exhibited hPPARγ agonism. According to our previous docking studies, SAR confirm that the hydrophobic nucleus (benzopyran-4-one or dihydrobenzopyran) is essential to activate PPARα and/or PPARγ, and the flexible linker (side alkyl chain) should containg at least C5-carbon atoms to activate PPARγ. By contrast, the polar head (“carboxylic group”) tolerated several oxygenated groups but also non-oxygenated motifs. Taking into account these key structural features, small polycerasoidol analogs might provide potential active molecules useful in the treatment of dyslipidemia and/or type 2 diabetes.     

Identification of a PPARδ agonist with partial agonistic activity on PPARγ

The discovery and optimization of a series of potent PPARδ full agonists with partial agonistic activity against PPARγ is described.     

PPAR与一些慢性疾病

慢性疾病如糖尿病、动脉粥样硬化和癌症等已成为危害人类健康的罪魁祸首。现有证据表明 ,一类称为过氧化物酶体增长因子活化受体 (ｐｅｒｏｘｉｓｏｍｅｐｒｏｌｉｆｅｒａｔｏｒ ａｃｔｉｖａｔｅｄｒｅ ｃｅｐｔｏｒｓ,ＰＰＡＲ)的细胞核受体 ,极有可能参与了这些疾病的形成。同时人们还发现ＰＰＡＲ的活性能被降血糖药物噻唑二酮 (ｔｈｉａｚｏ ｌｉｄｉｎｅｄｉｏｎｅｓ,ＴＺＤ)和降血脂药物苯氧乙酸酯(ｆｉｂｒａｔｅｓ)所调控。因此ＰＰＡＲ的研究将极有可能为这些疾病的治疗另辟蹊径。1 .ＰＰＡＲ概述ＰＰＡＲ最初克隆是作为基因转录…     

贵州草海国家级自然保护区小??巢址生境选择

为探究高寒湿地生态系统中小??Tachybaptus ruficollis巢址选择的影响因子,于2013年和2015年的4月29日—5月6日2次对贵州草海国家级自然保护区内的小??巢址和食物进行了调查。设置A区和B区,其中又划分为巢址斑块和对照斑块。以巢址为中心,记录巢址样方(1 m×1 m)和对照样方的生境因子并进行比较。结果表明:巢址样方的最高植物高度和离岸距离均显著大于对照样方。对巢址样方及其所在斑块共14个生境因子的特征进行主成分分析,结果表明:小??偏爱在植被植株较高、密度稀疏、矮小植株数量少的小斑块生境中营巢。食物丰富的区域小??巢穴数量多。该研究对小??物种保护有实践意义,对丰富高寒湿地生态系统鸟类巢址生境选择有理论意义。